To investigate the possible role of thyroid hormones in fetal lung maturation, we treated pregnant rabbits with 3,5-dimethyl-3'-isopropylthyronine (DIMIT), a thyroxine analog which binds to nuclear receptors in fetal lung. On days 24 and 25 of gestation does received diluent or 0.05-1 mglkg DIMIT in; fetuses were studied on day 26. We found no effect of DIMIT on viability, body weight, lung weight, lung wetldry ratio, or fetal plasma cortisol levels. NADPH-cytochrome C reductase, a known T4 induc ible enzyme, was increased 64% (p<0.01) in fetal liver with 1 mg kg DIMIT. MeanfSE values for the rate of 3~-choline incorporation into lecithin (pmol/mg tissuelh) by minced fetal lung and activity of phosphatidic acid phosphatase (PAPase, nmollmg prot/ min) in lung homogenate are shown below (*=p<0.001): 
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Similar results were found for incorporation of 3~-~l~c e r o l . We conclude that DIMIT crosses the rabbit placenta and stimulates lecithin synthesis and PAPase activity in fetal lung. Since similar effects occur with glucocorticoid treatment, these two hormones may act in part by controlling the same enzyme.
were studied prospectively following hospitalization for C (mean e 18.5 months)and B(mean age 7.5 months). Initial and follow-ul udies included viral cultures, serum IgE, allergy skin testsan ng function tests. Functional residual capacity (ERC), maximal w s at ERC (tmax FRC) derived from partial flow volume curves d response to exercise were measured in these subjects and7age tched normals (N) at the age of 4-7 years.
irth; a compliant perivascular tissue space accomodates excess eta1 lung liquid until its later removal; and type of delivery as no effect on the pattern of postnatal lung liquid drainage. These data demonstrate increases in HR, BP, CVP and r with falls in all flows as airway pressure increases. The newborn piglet responds in part to CPPB by vasoconstrbction, with resul tant dimunition in blood flow in at least three major vessels. Nasal CPAP was employed in the treatment of infants with RDS while arterial oxygen tension (PaO2) was continuously monitored by a special oxygen sensing electrode embedded in the wall of an umbilical artery catheter or transcutaneous oxygen tension(Tc02) was continuously monitored by a Roche sensor.
With nasal CPAP, some infants demonstrated wide fluctuations of PaOZ and TcO2 during crying or when the mouth was open. Oxygen tension fell as much as 60%. These changes of oxygen tensio are much greater than the reported changes from crying without CPAP. When these problems occurred a pressurized head hood was substituted for the nasal device, and the same pressures, pressure control system and gas flow were used. Following the change of equipment there was improvement and stability of the TcOa and Pa02 when the mouth was open and during crying. In some instances oxygen tension during quiet periods with the hood in place was more than 4-fold those found during quiet periods with naaal CPAP; increases were never less than 2-fold. Every infant who we monitored continuously with an oxygen sensor demonstrated the above changes.
These findings support our previous clinical observations that there are infants in whom nasal CPAP is ineffectual whereas other forms of CPAP administration are effective and raises the uestion as to whether nasal CPAP is the best means of PAP application.
